General Inquiries
ClinicalTrialsUA brings together high-performing sites from across Ukraine, strategically organized to meet your needs. This therapeutically aligned network includes diverse sites such as individual practices, academic centers of excellence, and site networks.
Corporate Responsibility at ClinicalTrialsUA
ClinicalTrialsUA is deeply committed to corporate responsibility, especially in the face of the global impact of COVID-19. We have a dedicated task force ensuring business continuity, monitoring the evolving global situation to prioritize the health and well-being of our staff, enrolled patients, and investigative sites. We also prioritize our customers’ projects and recognize the potential business impact on our sponsors.
Amidst this crisis, whether real or perceived, posing a threat to the smooth execution of our clinical protocols, we are dedicated to safeguarding the integrity of our trials. This involves ensuring that the quality and reliability of our trials remain uncompromised:
Risk Management
As part of our ongoing efforts to stay connected with clinical trial sites and monitor any incidents, we’re also developing backup plans to remotely assess data if the need arises.
We maintain complete control over our sponsors’ projects and take proactive measures to minimize potential risks. In addition to our sites, we’re collaborating closely with vendors to ensure we have the latest information on any potential impact they might have on overall operations.
Regulatory Support
Our regulatory team, well-versed in the regulatory systems of both Europe and the US, is diligently keeping our clients informed about the swiftly evolving regulatory environments. We’re proactively tracking these changes and offering practical advice to support our clients in advancing their projects.
ClinicalTrialsUA Prepared
to Navigate Ongoing Changes
Our skilled clinical operations team is ready to ensure each trial's success and compliance, even in these unprecedented times. We've implemented measures to remotely monitor trial sites, offering the flexibility needed for optimal outcomes.
Given the dynamic nature of the ongoing situation with COVID-19, we recognize the potential need for protocol adjustments and the crucial role of site engagement. We maintain continuous communication with our investigators to keep them promptly informed of any updates.
We are ready to address any statistical analysis challenges that may arise due to COVID-19, demonstrating our commitment to gathering accurate and reliable data essential for each project.
Interested in receiving a proposal from ClinicalTrialsUA? How you choose to get in touch depends on your query type
You are not CRO,
investigator or patient?
If you have another type of inquiry, please
click here
For CRO & Sponsors
Interested in ClinicalTrialsUA SMO's network, principal investigators, and capabilities?
For investigators | PI | Sites
We are looking for physicians, clinics, health systems or other research organizations that want to develop a strategic partnership offering clinical research as a care option for patients.
For patients
Patient care is at the heart of everything we do, and we are committed to ensuring you are treated with the utmost care and respect whilst maintaining the highest standard of research.
